VistaGen Therapeutics, Inc. Soared
Mon, Dec 16, 2019 at 05:30 PM
VistaGen Therapeutics, Inc. (VTGN:NASDAQ) jumped higher at $1.01, representing a gain of 44.3%. On Fri 13 Dec 19, VTGN:NASDAQ touched a New 2-Week High of $0.7. The stock got featured on our News Catalysts scanner on Wed 11 Dec 19 at 12:09 PM in the 'BIOTECH' category. From Fri 22 Nov 19, the stock recorded 57.14% Up Days and 46.67% Green Days
About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)
VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
Top 10 Gainers:
- Mirum Pharmaceuticals, Inc. (MIRM:NASDAQ), 110.99%
- Jason Industries, Inc. (JASN:NASDAQ), 90.7%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 70.55%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 44.29%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Taoping Inc. (TAOP:NASDAQ), 27.92%
- Verb Technology Company, Inc. (VERB:NASDAQ), 25.93%
- SIFCO Industries, Inc. (SIF:NYSEMKT), 25.56%
- TravelCenters of America Inc. (TA:NASDAQ), 24.41%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 24.12%